News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Daily News Benefits of Early SAVR for Asymptomatic Aortic Stenosis Persist a Decade On Todd Neale March 26, 2026
News Conference News CRT 2026 TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide L.A. McKeown March 19, 2026
News Conference News CRT 2026 PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years L.A. McKeown March 17, 2026
News Daily News Experience Matters as Ross Procedure Gains Popularity in North America Michael O'Riordan March 06, 2026
Presentation THT Abstracts 2026 Successful ViV-TAVR on a Deteriorated Mosaic Bioprosthetic Valve: A Promising Alternative to High-Risk Surgical Repair Presenter: Rani Marhaba March 02, 2026
News Daily News Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass Yael L. Maxwell January 14, 2026
News Conference News TCT 2025 PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI Michael O'Riordan October 27, 2025
News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Daily News Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI L.A. McKeown October 09, 2025
News Daily News Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair Todd Neale July 31, 2025
News Conference News EuroPCR 2025 Myval Noninferior to Other THVs at 1 Year, but Questions Persist L.A. McKeown May 21, 2025
News Daily News Registry Data Rekindle Talk Over the Best Valve for TAVI in Small Annuli Caitlin E. Cox May 19, 2025
News Conference News SCAI 2025 More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected L.A. McKeown May 02, 2025
News Daily News TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms Caitlin E. Cox April 28, 2025
News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025